Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LO...

por Tsuchiya-Kawano, Yuko, Shiraishi, Yoshimasa, Kiyomi, Fumiaki, Okamoto, Isamu
Publicado 2021

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART tri...

por Shiraishi, Yoshimasa, Kishimoto, Junji, Shimose, Takayuki, Toi, Yukihiro, Sugawara, Shunichi, Okamoto, Isamu
Publicado 2022

Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases

por Shiraishi, Yoshimasa, Shimose, Takayuki, Tsuchiya-Kawano, Yuko, Ishii, Hidenobu, Daga, Haruko, Ito, Kentaro, Saruwatari, Koichi, Okamoto, Isamu
Publicado 2022

Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum‐based chemotherapy

por Nakatsuru, Kousei, Tsubouchi, Kazuya, Hirahata, Minori, Nakashima, Tadayuki, Takahata, Yuriko, Okamatsu, Yuki, Shiraishi, Yoshimasa, Okamoto, Isamu, Harada, Taishi
Publicado 2023

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

por Li, Heyan, Takayama, Koichi, Wang, Shuo, Shiraishi, Yoshimasa, Gotanda, Keisuke, Harada, Taishi, Furuyama, Kazuto, Iwama, Eiji, Ieiri, Ichiro, Okamoto, Isamu, Nakanishi, Yoichi
Publicado 2014

Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untre...

por Takayama, Koichi, Takeshita, Masafumi, Inoue, Koji, Ichiki, Masao, Fujita, Masaki, Harada, Taishi, Shiraishi, Yoshimasa, Wataya, Hiroshi, Tokunaga, Shoji, Yamada, Tadaaki, Uchino, Junji, Sugio, Kenji
Publicado 2020

Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: A case report

por TOYOKAWA, GOUJI, TAGUCHI, KENICHI, KOJO, MIYAKO, TOYOZAWA, RYO, INAMASU, EIKO, MORODOMI, YOSUKE, SHIRAISHI, YOSHIMASA, TAKENAKA, TOMOYOSHI, HIRAI, FUMIHIKO, YAMAGUCHI, MASAFUMI, SETO, TAKASHI, TAKENOYAMA, MITSUHIRO, ICHINOSE, YUKITO
Publicado 2013

Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, P...

por Hata, Akito, Shiraishi, Yoshimasa, Inui, Naoki, Okada, Morihito, Morise, Masahiro, Akiyoshi, Kohei, Takeda, Masayuki, Watanabe, Yasutaka, Sugawara, Shunichi, Shinagawa, Naofumi, Kubota, Kaoru, Saeki, Toshiaki, Tamura, Tomohide
Publicado 2022

Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small...

por Ibusuki, Ritsu, Yoneshima, Yasuto, Hashisako, Mikiko, Matsuo, Norikazu, Harada, Taishi, Tsuchiya-Kawano, Yuko, Kishimoto, Junji, Ota, Keiichi, Shiraishi, Yoshimasa, Iwama, Eiji, Tanaka, Kentaro, Oda, Yoshinao, Okamoto, Isamu
Publicado 2022

Phase 1 study of DS‐1205c combined with gefitinib for EGFR mutation‐positive non‐small cell lung cancer

por Goto, Koichi, Shiraishi, Yoshimasa, Murakami, Haruyasu, Horinouchi, Hidehito, Toyozawa, Ryo, Takeda, Masayuki, Uno, Makiko, Crawford, Nigel, McGill, Joseph, Jimbo, Takeshi, Ishigami, Masato, Takayama, Gensuke, Nakayama, Shintaro, Ohwada, Shoichi, Nishio, Makoto
Publicado 2023

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)

por Akamatsu, Hiroaki, Teraoka, Shunsuke, Takamori, Shinkichi, Miura, Satoru, Hayashi, Hidetoshi, Hata, Akito, Toi, Yukihiro, Shiraishi, Yoshimasa, Mamesaya, Nobuaki, Sato, Yuki, Furuya, Naoki, Oyanagi, Jun, Koh, Yasuhiro, Misumi, Toshihiro, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicado 2022

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

por Sakata, Shinya, Otsubo, Kohei, Yoshida, Hisako, Ito, Kentaro, Nakamura, Atsushi, Teraoka, Shunsuke, Matsumoto, Naohisa, Shiraishi, Yoshimasa, Haratani, Koji, Tamiya, Motohiro, Ikeda, Satoshi, Miura, Satoru, Tanizaki, Junko, Omori, Shota, Yoshioka, Hiroshige, Hata, Akito, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicado 2021

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630

por Taniguchi, Yuri, Shimokawa, Tsuneo, Takiguchi, Yuichi, Misumi, Toshihiro, Nakamura, Yukiko, Kawashima, Yosuke, Furuya, Naoki, Shiraishi, Yoshimasa, Harada, Toshiyuki, Tanaka, Hisashi, Miura, Satoru, Uchiyama, Ayumi, Nakahara, Yoshiro, Tokito, Takaaki, Naoki, Katsuhiko, Bessho, Akihiro, Goto, Yasuhiro, Seike, Masahiro, Okamoto, Hiroaki
Publicado 2022

Pleuropulmonary Paragonimiasis with Multiple Nodules in the Pleura

por Ogata, Hiroaki, Harada, Eiji, Moriya, Soichiro, Fukuyama, Satoru, Suzuki, Kunihiro, Shiraishi, Yoshimasa, Ando, Hiroyuki, Uryu, Kazuyasu, Shinozaki, Seiji, Ide, Maako, Sakamoto, Aiko, Nakanishi, Takayuki, Hamada, Naoki, Yoneshima, Yasuto, Ota, Keiichi, Kohashi, Kenichi, Tateishi, Yuki, Miyashita, Yu, Oda, Yoshinao, Matsumoto, Koichiro
Publicado 2020

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer

por Inoue, Hiroyuki, Tsutsumi, Hirono, Tanaka, Kentaro, Iwama, Eiji, Shiraishi, Yoshimasa, Hirayama, Aiko, Nakanishi, Takayuki, Ando, Hiroyuki, Nakajima, Maako, Shinozaki, Seiji, Ogata, Hiroaki, Uryu, Kazuyasu, Okamura, Koji, Kimura, Shinichi, Ogawa, Tomohiro, Ota, Keiichi, Yoneshima, Yasuto, Hamada, Naoki, Nakanishi, Yoichi, Okamoto, Isamu
Publicado 2021

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

por Fujimoto, Daichi, Miura, Satoru, Tomii, Keisuke, Sumikawa, Hiromitsu, Yoshimura, Kenichi, Wakuda, Kazushige, Oya, Yuko, Yokoyama, Toshihide, Kijima, Takashi, Asao, Tetsuhiko, Tamiya, Motohiro, Nakamura, Atsushi, Yoshioka, Hiroshige, Tokito, Takaaki, Murakami, Shuji, Tamiya, Akihiro, Yokouchi, Hiroshi, Watanabe, Satoshi, Yamaguchi, Ou, Morinaga, Ryotaro, Jodai, Takayuki, Ito, Kentaro, Shiraishi, Yoshimasa, Kogure, Yoshihito, Shibaki, Ryota, Yamamoto, Nobuyuki
Publicado 2023

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients

por Oku, Yuka, Toyokawa, Gouji, Wakasu, Sho, Kinoshita, Fumihiko, Takamori, Shinkichi, Watanabe, Kenji, Haratake, Naoki, Nagano, Taichi, Kosai, Keisuke, Takada, Kazuki, Fujimoto, Airi, Higashijima, Kodo, Shiraishi, Yoshimasa, Tanaka, Kentaro, Takeoka, Hiroaki, Okamoto, Masaki, Yamashita, Takanori, Shimokawa, Mototsugu, Shoji, Fumihiro, Yamazaki, Koji, Okamoto, Tatsuro, Seto, Takashi, Ueda, Hitoshi, Takeo, Sadanori, Nakashima, Naoki, Okamoto, Isamu, Takenaka, Tomoyoshi, Yoshizumi, Tomoharu
Publicado 2023